GlaxoSmithKline Receives First European Approval For Wellbutrin XR®

Mon, 22 Jan 2007 02:00 PM EST

... GlaxoSmithKline announced today that Wellbutrin XR® (bupropion hydrochloride modified-release tablets), has been granted a marketing license in The Netherlands for the treatment of adult patients with major depressive episodes. The medicine is also considered approvable by the regulatory agencies of 21 other countries under the Decentralised Procedure. [click link for full article] ...